Engineered spider toxin could be the future of anti-venom vaccines
New engineered spider protein could be the start of a new generation of anti-venom vaccines, potentially saving thousands of lives worldwide. The new protein, created from parts of a toxin from the reaper ...
Medications
May 09, 2013 |
5 / 5 (3) |
0
|
Monoclonal antibody appears effective and safe in asthma Phase IIa trial
A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to U. S. researchers.
Diseases, Conditions, Syndromes
May 21, 2013 |
5 / 5 (1) |
0
Estimates reveal low population immunity to new bird flu virus H7N9 in humans
The level of immunity to the recently circulating H7N9 influenza virus in an urban and rural population in Vietnam is very low, according to the first population level study to examine human immunity to the virus, which was ...
Diseases, Conditions, Syndromes
May 21, 2013 |
5 / 5 (1) |
0
|
